Cannara Biotech Inc.
LOVE.V
TSX
| 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -18.00% | 27.20% | 38.18% | -60.11% | 183.00% |
| Total Depreciation and Amortization | 80.86% | -21.27% | 1.17% | -12.59% | 16.36% |
| Total Amortization of Deferred Charges | -- | -- | 17.36% | -88.44% | -- |
| Total Other Non-Cash Items | -27.70% | 35.20% | -11.79% | 133.94% | -208.15% |
| Change in Net Operating Assets | -165.15% | 173.75% | -2,709.07% | 242.07% | -95.84% |
| Cash from Operations | -79.16% | 654.88% | -142.01% | 82.27% | -26.69% |
| Capital Expenditure | 31.91% | -52.93% | -15.98% | -145.74% | 84.08% |
| Sale of Property, Plant, and Equipment | 803.54% | -- | -- | -73.81% | -99.45% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 55.81% | -23.06% | 71.67% | -11.48% | 16.55% |
| Cash from Investing | 40.35% | -55.68% | -14.38% | -167.91% | 54.03% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | 60.66% | -926.12% | 72.92% | -4.75% | 81.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -30.57% | 31.82% | -19.15% | 9.95% | -333.50% |
| Cash from Financing | 30.70% | -95.09% | -18.68% | 36.33% | -51.47% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -100.52% | 282.85% | -237.45% | 213.54% | -50.71% |